M-M-R II
Measles, mumps, rubella — live attenuated · MMR and MMRV (measles, mumps, rubella, chickenpox)
Health Canada DIN 00466085. Check the product and formulation on your record before using a schedule.
Plan doses for this product →At a glance
- Brand
- M-M-R II
- DIN
00466085- Vaccine
- Measles, mumps, rubella — live attenuated
- Presentation
- 0.5 mL · powder for solution · subcutaneous or intramuscular · 12 months and older
- Live vaccine
- Yes
Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with the Care365 clinical team or doctor.
Official product information
Use the DIN to confirm this exact product in Health Canada's Drug Product Database.
Read product monograph (PDF) ↗
A listed product may not be stocked or publicly funded.
Dose schedules involving this product
These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination.
| Schedule | Doses | Who it applies to |
|---|---|---|
| MMR — children and adolescents (12 months to 17 years), two doses Dose 1 at 12 to 15 months and dose 2 at 18 months or later; susceptible adolescents get two doses at least 4 weeks apart. | 2 doses | Two doses of measles-containing vaccine. Children: first dose at 12 to 15 months of age, second at 18 months or any time after, but no later than around school entry. Susceptible adolescents 13 to 17 years: 2 doses of MMR at least 4 weeks apart. Infants 6 to 11 months travelling to high-risk areas may receive an early dose that does not count toward the series. |
| MMR — adult born in 1970 or later without immunity, one dose One dose for susceptible adults 18 and older born in or after 1970. | 1 dose | Adults born in 1970 or later without documented immunity receive one dose of MMR. Health care workers, travellers, military personnel and post-secondary students should receive two doses instead. Adults born before 1970 are generally presumed immune. |
| MMR — health care workers, travellers, students, military: two doses Two doses at least 4 weeks apart for adults at higher exposure risk. | 2 doses | For susceptible adults at higher measles exposure risk (health care workers, travellers, post-secondary students, military): two doses of MMR with a minimum interval of 4 weeks. |
Pregnancy and breastfeeding
Family guidance on pregnancy: Generally contraindicated: MMR and MMRV are live vaccines. Avoid pregnancy for 4 weeks after a dose. Vaccination may be considered during a measles or rubella outbreak.
Family guidance on breastfeeding: Recommended if not immune.
This guidance applies to the vaccine family. Confirm this product's details in the monograph and with your clinician. Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026.
Sources and next steps
- Measles vaccines: Canadian Immunization Guide — Chapter revised April 2015 · partial update June 2025
- Health Canada product record
General information only. A suggested date is not an appointment or a prescription; the Care365 clinical team or doctor confirms what you need. Clinical rules reviewed on 2026-09-27.
Review with Care365